Protagonist Therapeutics
PTGX
#3935
Rank
NZ$4.27 B
Marketcap
$71.71
Share price
-2.55%
Change (1 day)
102.96%
Change (1 year)

Earnings for Protagonist Therapeutics (PTGX)

Earnings in 2024 (TTM): NZ$0.29 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current earnings are NZ$0.32 Billion. In 2023 the company made an earning of -NZ$0.15 Billion, an increase over its 2022 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protagonist Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.29 B-308.48%
2023 -NZ$0.15 Billion-38.02%
2022 -NZ$0.23 Billion1.47%
2021 -NZ$0.23 Billion93.62%
2020 -NZ$0.12 Billion-16.74%
2019 -NZ$0.14 Billion96.06%
2018 -NZ$70.46 Million7.48%
2017 -NZ$65.55 Million-0.59%
2016 -NZ$65.94 Million150.22%
2015 -NZ$26.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion-177.86%๐Ÿ‡บ๐Ÿ‡ธ USA